Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC
Status:
Terminated
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This trial will compare the efficacy of the docetaxel and gemcitabine combination versus
monotherapy with gemcitabine as first-line treatment in elderly patients with advanced NSCLC